Literature DB >> 26051399

Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence.

Juan L Gomez1, Christopher L Cunningham2, Deborah A Finn3, Emily A Young2, Lily K Helpenstell2, Lindsey M Schuette2, Tara L Fidler2, Therese A Kosten4, Andrey E Ryabinin2.   

Abstract

An effort has been mounted to understand the mechanisms of alcohol dependence in a way that may allow for greater efficacy in treatment. It has long been suggested that drugs of abuse seize fundamental reward pathways and disrupt homeostasis to produce compulsive drug seeking behaviors. Ghrelin, an endogenous hormone that affects hunger state and release of growth hormone, has been shown to increase alcohol intake following administration, while antagonists decrease intake. Using rodent models of dependence, the current study examined the effects of two ghrelin receptor antagonists, [DLys3]-GHRP-6 (DLys) and JMV2959, on dependence-induced alcohol self-administration. In two experiments adult male C57BL/6J mice and Wistar rats were made dependent via intermittent ethanol vapor exposure. In another experiment, adult male C57BL/6J mice were made dependent using the intragastric alcohol consumption (IGAC) procedure. Ghrelin receptor antagonists were given prior to voluntary ethanol drinking. Ghrelin antagonists reduced ethanol intake, preference, and operant self-administration of ethanol and sucrose across these models, but did not decrease food consumption in mice. In experiments 1 and 2, voluntary drinking was reduced by ghrelin receptor antagonists, however this reduction did not persist across days. Despite the transient effects of ghrelin antagonists, the drugs had renewed effectiveness following a break in administration as seen in experiment 1. The results show the ghrelin system as a potential target for studies of alcohol abuse. Further research is needed to determine the central mechanisms of these drugs and their influence on addiction in order to design effective pharmacotherapies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ethanol vapor; Ghrelin; Intragastric infusions; Self-administration; Two-bottle choice

Mesh:

Substances:

Year:  2015        PMID: 26051399      PMCID: PMC4537402          DOI: 10.1016/j.neuropharm.2015.05.026

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  42 in total

1.  Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41).

Authors:  Deborah A Finn; Christopher Snelling; Andrea M Fretwell; Michelle A Tanchuck; Lisa Underwood; Maury Cole; John C Crabbe; Amanda J Roberts
Journal:  Alcohol Clin Exp Res       Date:  2007-03-31       Impact factor: 3.455

2.  The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats.

Authors:  Brendan M Walker; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2007-01       Impact factor: 3.455

3.  Paradoxical aversive conditioning with ethanol.

Authors:  C L Cunningham; J G Linakis
Journal:  Pharmacol Biochem Behav       Date:  1980-03       Impact factor: 3.533

4.  Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.

Authors:  Charles J Heyser; Kelly Moc; George F Koob
Journal:  Neuropsychopharmacology       Date:  2003-04-09       Impact factor: 7.853

5.  Excessive ethanol drinking following a history of dependence: animal model of allostasis.

Authors:  A J Roberts; C J Heyser; M Cole; P Griffin; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-06       Impact factor: 7.853

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.

Authors:  Lorenzo Leggio; William H Zywiak; Samuel R Fricchione; Steven M Edwards; Suzanne M de la Monte; Robert M Swift; George A Kenna
Journal:  Biol Psychiatry       Date:  2014-03-25       Impact factor: 13.382

8.  Alcohol dependence is associated with reduced plasma and fundic ghrelin levels.

Authors:  A Badaoui; C De Saeger; J Duchemin; D Gihousse; P de Timary; P Stärkel
Journal:  Eur J Clin Invest       Date:  2008-04-17       Impact factor: 4.686

9.  Reestablishing an intragastric ethanol self-infusion model in rats.

Authors:  Tara L Fidler; Tara W Clews; Christopher L Cunningham
Journal:  Alcohol Clin Exp Res       Date:  2006-03       Impact factor: 3.455

Review 10.  Animal models of alcohol withdrawal.

Authors:  H C Becker
Journal:  Alcohol Res Health       Date:  2000
View more
  17 in total

1.  Tigecycline Reduces Ethanol Intake in Dependent and Nondependent Male and Female C57BL/6J Mice.

Authors:  Susan E Bergeson; Michelle A Nipper; Jeremiah Jensen; Melinda L Helms; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2016-11-14       Impact factor: 3.455

2.  Effects of ethanol on plasma ghrelin levels in the rat during early and late adolescence.

Authors:  Kati L Healey; Justine D Landin; Kira Dubester; Sandra Kibble; Kristin Marquardt; Julianna N Brutman; Jon F Davis; H Scott Swartzwelder; L Judson Chandler
Journal:  Alcohol       Date:  2020-01-07       Impact factor: 2.405

Review 3.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

4.  Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis.

Authors:  Grzegorz Godlewski; Resat Cinar; Nathan J Coffey; Jie Liu; Tony Jourdan; Bani Mukhopadhyay; Lee Chedester; Ziyi Liu; Douglas Osei-Hyiaman; Malliga R Iyer; Joshua K Park; Roy G Smith; Hiroshi Iwakura; George Kunos
Journal:  Cell Metab       Date:  2019-05-16       Impact factor: 27.287

5.  Inhibition of Glyoxalase 1 reduces alcohol self-administration in dependent and nondependent rats.

Authors:  Giordano de Guglielmo; Dana E Conlisk; Amanda M Barkley-Levenson; Abraham A Palmer; Olivier George
Journal:  Pharmacol Biochem Behav       Date:  2018-03-02       Impact factor: 3.533

Review 6.  The gut in the brain: the effects of bariatric surgery on alcohol consumption.

Authors:  Ashley N Blackburn; Andras Hajnal; Lorenzo Leggio
Journal:  Addict Biol       Date:  2016-08-31       Impact factor: 4.280

7.  The Leu72Met Polymorphism of the Prepro-ghrelin Gene is Associated With Alcohol Consumption and Subjective Responses to Alcohol: Preliminary Findings.

Authors:  Petra Suchankova; Jia Yan; Melanie L Schwandt; Bethany L Stangl; Elisabet Jerlhag; Jörgen A Engel; Colin A Hodgkinson; Vijay A Ramchandani; Lorenzo Leggio
Journal:  Alcohol Alcohol       Date:  2017-07-01       Impact factor: 2.826

8.  Early life adversity and appetite hormones: The effects of smoking status, nicotine withdrawal, and relapse on ghrelin and peptide YY during smoking cessation.

Authors:  Mustafa al'Absi; Briana DeAngelis; Motohiro Nakajima; Dorothy Hatsukami; Sharon Allen
Journal:  Addict Behav       Date:  2021-02-08       Impact factor: 4.591

Review 9.  Hunger and Satiety Gauge Reward Sensitivity.

Authors:  Ryan Michael Cassidy; Qingchun Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-18       Impact factor: 5.555

10.  Effects of exogenous ghrelin administration and ghrelin receptor blockade, in combination with alcohol, on peripheral inflammatory markers in heavy-drinking individuals: Results from two human laboratory studies.

Authors:  Mehdi Farokhnia; Jeanelle Portelli; Mary R Lee; Gray R McDiarmid; Vikas Munjal; Kelly M Abshire; Jillian T Battista; Brittney D Browning; Sara L Deschaine; Fatemeh Akhlaghi; Lorenzo Leggio
Journal:  Brain Res       Date:  2020-04-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.